Cargando…

The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease

BACKGROUND: The differentiation between hypertrophic cardiomyopathy (HCM) and hypertensive heart disease (HHD) is challenging due to similar myocardial hypertrophic phenotype. The purpose of this study is to evaluate the feasibility of cardiovascular magnetic resonance feature tracking (CMR-FT) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shengliang, Li, Yunling, Zhao, Yanming, Wang, Xueying, Wu, Zhiyuan, Gu, Xia, Xu, Bing, Li, Ye, Tian, Jinwei, Cui, Jinjin, Wang, Guokun, Yu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130652/ https://www.ncbi.nlm.nih.gov/pubmed/35647085 http://dx.doi.org/10.3389/fcvm.2022.865615

Ejemplares similares

Prognostic significance of myocardial salvage assessed by cardiac magnetic resonance in reperfused ST-segment elevation myocardial infarction
por: Li, Yunling, et al.
Publicado: (2022)

Exuberant late gadolinium enhancement in hypertrophic cardiomyopathy as a precursor to ‘burn out’
por: Gweun, John, et al.
Publicado: (2022)

Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy
por: Ye, Yang, et al.
Publicado: (2021)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population
por: Lander, Bradley S., et al.
Publicado: (2022)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
por: Smith, Brandon M, et al.
Publicado: (2013)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
por: Alis, Deniz, et al.
Publicado: (2021)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
por: Chayanopparat, Punyanuch, et al.
Publicado: (2023)

Free-Breathing Motion-Corrected Single-Shot Phase-Sensitive Inversion Recovery Late-Gadolinium-Enhancement Imaging: A Prospective Study of Image Quality in Patients with Hypertrophic Cardiomyopathy
por: Cha, Min Jae, et al.
Publicado: (2021)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
por: Strijack, Bradford, et al.
Publicado: (2008)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

Different phenotype of left atrial function impairment in patients with hypertrophic cardiomyopathy and hypertension: comparison of healthy controls
por: Li, Hongwen, et al.
Publicado: (2023)

Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

Precision and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

A Rare Case of Hypertrophic Cardiomyopathy with Subendocardial Late Gadolinium Enhancement in an Apical Aneurysm with Thrombus
por: Morita, Yusuke, et al.
Publicado: (2014)

Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Improved prediction of adverse events in hypertrophic cardiomyopathy with quantitative late gadolinium enhancement and myocardial strain
por: Brahmanandam, Vikram, et al.
Publicado: (2016)

Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy
por: Amano, Yasuo, et al.
Publicado: (2018)

Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort
por: Gangadharakaimal, Harikrishnan, et al.
Publicado: (2023)

Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy
por: Gu, Zi-Yi, et al.
Publicado: (2023)

Self-Gated Late Gadolinium Enhancement at 7T to Image Rats with Reperfused Acute Myocardial Infarction
por: Wang, Lei, et al.
Publicado: (2018)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

High Sensitivity of Late Gadolinium Enhancement for Predicting Microscopic Myocardial Scarring in Biopsied Specimens in Hypertrophic Cardiomyopathy
por: Konno, Tetsuo, et al.
Publicado: (2014)

Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis
por: Weng, Zhen, et al.
Publicado: (2016)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Doesch, Christina, et al.
Publicado: (2017)

Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
por: Rodriguez-Granillo, Gaston A., et al.
Publicado: (2016)

Relationship Between Obstructive Sleep Apnea and Late Gadolinium Enhancement and Their Effect on Cardiac Arrhythmias in Patients with Hypertrophic Obstructive Cardiomyopathy
por: Wang, Shengwei, et al.
Publicado: (2021)

Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Nie, Changrong, et al.
Publicado: (2021)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Evaluation of Exercise Tolerance in Non-obstructive Hypertrophic Cardiomyopathy With Myocardial Work and Peak Strain Dispersion by Speckle-Tracking Echocardiography
por: Su, Ye, et al.
Publicado: (2022)

Aortic Coarctation Associated With Hypertrophic Cardiomyopathy in a Woman With Hypertension and Syncope: A Case Report With 8-Year Follow-Up
por: Yang, Hong, et al.
Publicado: (2022)

Cardiac phase-resolved late gadolinium enhancement imaging
por: Weingärtner, Sebastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_74qhihiuhf237d2kefp2p1ia76